Clinical Trial Update: Fecal Microbiota Transplantation in Pediatric Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating fecal microbiota transplantation in pediatric patients with inflammatory bowel diseases, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Inflammatory Bowel Diseases (IBD), Crohn's Disease (CD) | Phase 1 | Status: COMPLETED | Results posted: 2021-02-04